The family that brought OxyCotin to market has agreed to a $7.4 billion nationwide settlement, and Utah is poised to get a ...

For people who study the opioid epidemic, 2025 marks a grim anniversary: It has been 30 years since the Food and Drug ...

Passing the Alternatives to PAIN Act would be an excellent way for Trump to uphold his promise to “Make America Healthy Again ...

Utah will receive $57 million to combat the state’s opioid crisis if it joins the $7.4 billion settlement against the Sackler ...

Proponents of the plan to equip paramedics with buprenorphine call it the "missing link" in the bridge to recovery for many ...

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running ...

The Florida Attorney General’s Office says the settlement will help fund opioid addiction treatment, prevention and recovery ...

Phillipsburg's LEAD program helps homeless, mentally challenged and disadvantaged individuals stay crime-free and rebuild ...

Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the ...

Opioid-related neurocognitive symptoms among patients on long-term opioid therapy were most prevalent during the course of therapy.

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...

For individuals reporting cannabis use, the odds of opioid misuse are reduced among individuals in states with medical cannabis legalization.